Secukinumab homecare for Northern HSC Trust goes to Sciensus
- Northern Health and Social Care Trust
- Northern Ireland
- Direct award
- 10 September 2026 to 31 August 2029
Northern Health and Social Care Trust buys secukinumab, sold as Cosentyx, from Sciensus Pharma Services through a homecare service.
The contract covers pre-filled pens and syringes in 150 mg and 300 mg strengths. Sciensus delivers them directly to patients.
The trust awarded the £4m contract directly in August 2026. It runs for up to three years, to August 2029.
Contract ends August 2029
- What
- Homecare medicines services
- Supplier
- Sciensus Pharma Services Limited
- Value
- £4m
- How it was bought
- Direct award
- Dates and next
- Sep 2026 to Aug 2029